Delivery Order SPE2DB24D2013-SPE2DB25FCHCM

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,193.38 Firm Fixed Price Delivery Order is for the supply of 4566088090 CYCLOSPORINE 0.05% EYE EMULS 60S and has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,181.48 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty medication, with a period of performance through November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.16 firm fixed price delivery order is for the supply of 4565747846 ! CYCLOSPORINE 0.05% EYE EMULSION 30S. The contract has a period of performance through September 11, 2024 and was awarded on September 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,178.20 firm fixed-price delivery order is for the supply of 4566248822 - CYCLOSPORINE 0.05% EYE EMULS 30S, with a period of performance through October 29, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,784.10 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty medication. The contract has a completion date of July 5, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of CYCLOSPORINE 0.05% EYE EMULS 30S, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order valued at $10,354.96 with a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated under any set-aside program. The contract is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,812.91 delivery order contract is for the supply of 4561683545 - CYCLOSPORINE 0.05% EYE EMULS 30S, a specialty pharmaceutical product. The contract is a firm fixed-price Delivery Order with an ultimate completion date of August 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Cyclosporine 0.05% eye emulsion. The $3,945.60 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,618.38 firm fixed-price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a specialty medication, with a completion date of October 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $2,650.58 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a child contract under its parent company Cencora, Inc. The contract has an ultimate completion date of August 31, 2023 and was awarded on August 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCHCM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,436.21 firm fixed-price delivery order is for the supply of 4566821688 CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is part of that broader IDC, enabling the efficient government procurement of essential medical commodities. The contract award did not have any set-aside designation, indicating open competition.

Generated 4/3/25, 11:12 AM